ICCM - IceCure shares rally 53% on ProSense kidney cancer study
2023-11-28 09:39:12 ET
More on IceCure Medical
- IceCure Medical Ltd (ICCM) Q3 2023 Earnings Call Transcript
- IceCure stock climbs 10% amid FDA appeal, earnings report
- IceCure Medical 9M GAAP EPS of -$0.26, revenue of $2M
- Seeking Alpha’s Quant Rating on IceCure Medical
- Historical earnings data for IceCure Medical
For further details see:
IceCure shares rally 53% on ProSense kidney cancer study